Skip to main content
ZheJiang Tailin Bioengineering Co.,Ltd logo

ZheJiang Tailin Bioengineering Co.,Ltd — Investor Relations & Filings

Ticker · 300813 ISIN · CNE100003S89 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,000 across all filing types
Latest filing 2023-05-22 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 300813

About ZheJiang Tailin Bioengineering Co.,Ltd

https://www.tailingood.com

ZheJiang Tailin Bioengineering Co.,Ltd. specializes in the research, development, and manufacturing of high-tech equipment for life sciences and pharmaceutical engineering. The company provides integrated solutions for microbial control, sterility testing, and aseptic processing. Its core product portfolio includes sterility test canisters and pumps, microbial limit testing systems, and hydrogen peroxide vapor (VHP) decontamination units. Tailin also develops advanced isolator technology for containment and aseptic applications, alongside analytical instruments such as Total Organic Carbon (TOC) analyzers and filter integrity testers. These products are designed to meet international regulatory standards, including GMP, USP, and EP. The company serves sectors such as biopharmaceuticals, medical devices, and laboratory research, focusing on product safety and quality through specialized engineering and microbial detection technologies.

Recent filings

Filing Released Lang Actions
第三届监事会第十二次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at the 12th meeting of the third Supervisory Board of Zhejiang Tailin Biotechnology Co., Ltd. It details the meeting's convening, attendance, and the approval of specific proposals related to the cancellation and vesting of restricted stock incentive plans. The document includes voting results and references to related disclosures on a regulatory information website. It does not contain financial statements or detailed financial analysis but is a formal disclosure of board-level decisions. This fits the category of Board/Management Information (MANG), which covers announcements of changes or decisions by company boards or senior management bodies. The document length is short and focused on meeting resolutions, not a full report or financial release.
2023-05-22 Chinese
第三届董事会第十五次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at the fifteenth meeting of the third board of directors of Zhejiang Tailin Biotechnology Co., Ltd. It details decisions on stock incentive plans, capital changes, and amendments to the company charter. The text includes voting results and mentions independent directors' opinions. The document is an official disclosure of board meeting decisions, not a full management report or annual report. It fits the category of Board/Management Information (MANG), which covers announcements of changes or decisions by the board of directors. The document length is short (1702 characters), and it is not a report publication announcement or regulatory filing. Therefore, the classification is MANG with high confidence.
2023-05-22 Chinese
监事会关于2022年限制性股票激励计划首次授予部分第一个归属期归属名单的核查意见
Regulatory Filings Classification · 95% confidence The document is a verification opinion from the Supervisory Board regarding the first vesting list of a 2022 restricted stock incentive plan. It discusses compliance with laws and regulations, the qualification of incentive recipients, and approval of stock vesting. It is not a full financial report, earnings release, or management discussion. It is a regulatory announcement related to stock incentive plan compliance and approval, which does not fit into categories like Annual Report, Earnings Release, or Capital/Financing Update. Given the nature and length (791 characters), it is best classified as a Regulatory Filing (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other categories.
2023-05-22 Chinese
关于2022年限制性股票激励计划首次授予部分第一个归属期归属条件成就的公告
Remuneration Information Classification · 95% confidence The document is a detailed announcement from Zhejiang Tailin Biotechnology Co., Ltd. regarding the achievement of the first vesting period conditions for the 2022 restricted stock incentive plan's initial grant portion. It includes extensive information about the stock incentive plan, approval procedures, vesting conditions, performance targets, individual and company-level assessments, and the number of shares vested. It also contains opinions from independent directors, the supervisory board, legal counsel, and independent financial advisors. The document is not a full annual or interim financial report, nor is it a simple announcement of a report publication. It is a formal disclosure related to the company's stock incentive plan and the vesting of restricted shares, which is a form of remuneration information for executives and employees. Therefore, the document fits best under the category of Remuneration Information (DEF 14A), which covers reports detailing compensation for top executives and directors, including stock incentive plans and their vesting.
2023-05-22 Chinese
关于变更注册资本并修订公司章程的公告
Share Issue/Capital Change Classification · 95% confidence The document is an announcement from Zhejiang Tailin Biotechnology Co., Ltd. regarding changes in registered capital and amendments to the company's articles of association. It details the increase in total shares due to equity distribution and restricted stock incentives, and the corresponding revisions to the company's charter. The document is a formal announcement of corporate governance changes related to capital structure and company bylaws, approved by the board without requiring shareholder meeting approval. It does not contain full financial statements or detailed financial performance data, nor is it a report or transcript. It is not a simple notice of report publication or certification. The content fits best under a regulatory announcement category related to capital changes and governance amendments. Given the specific focus on capital changes and articles of association amendments, the most appropriate classification is Share Issue/Capital Change (SHA). The document length is short (1324 characters), consistent with an announcement rather than a full report.
2023-05-22 Chinese
公司章程
Governance Information Classification · 100% confidence The document is titled as the Articles of Association (章程) of Zhejiang Tailin Bioengineering Co., Ltd. It contains detailed provisions on company organization, shareholder rights, board structure, management, financial accounting, and other governance matters. It references relevant laws and regulations such as the Company Law, Securities Law, and listing rules. The content is a comprehensive governance document outlining the internal rules and structure of the company rather than a financial report, announcement, or meeting transcript. Therefore, it fits the category of Governance Information (CGR). The document length is substantial (15,000 characters), indicating it is the full governance document, not just an announcement or summary.
2023-05-22 Chinese

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.